SCHEMBL2360158

SCHEMBL2360158

COc1ccc(N2CCN(c3ccc(Cl)cc3)S2(=O)=O)nc1N1CCN(C)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 7/20 0.44
HTR6 P50406 3/20 0.43
HTR1A P08908 1/20 0.43
HTR1D P28221 1/20 0.43
HTR1B P28222 1/20 0.43
HTR2A P28223 1/20 0.43
HTR2C P28335 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.42
SIRT6 Q8N6T7 1/20 0.40
HTR3A P46098 1/20 0.40
GAA P10253 3/20 0.40
MAPT P10636 2/20 0.40
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
HPGD P15428 1/20 0.39
BRD4 O60885 1/20 0.38
MAT2A P31153 1/20 0.38
POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12445260 0.90 MAPT (0.45) HRH4HTR1AHTR1DHTR1BSMN1; SMN2
SCHEMBL2360090 0.89 CYP1A2 (0.43) HRH4HTR6HTR1AHTR1DHTR1B
SCHEMBL14733345 0.85 HRH4 (0.42) HRH4HTR1AHTR3AGAAMAPT
SCHEMBL2333076 0.82 HRH4 (0.42) HRH4HTR6HTR1AHTR1DHTR1B
SCHEMBL14733346 0.79 HRH4 (0.42) HRH4HTR6SMN1; SMN2MAPTNPC1
SCHEMBL2360549 0.79 HRH4 (0.42) HRH4HTR6HTR1AHTR1DHTR1B
SCHEMBL14733343 0.73 KMT2A (0.44) HRH4HTR3AMAPTKDM4EALDH1A1
SCHEMBL2360469 0.72 HRH4 (0.45) HRH4HTR1AHTR1DHTR1BSMN1; SMN2
SCHEMBL2328041 0.70 HTR2A (0.44) HRH4HTR1AHTR1DHTR1BHTR2A
SCHEMBL2359748 0.68 HRH4 (0.43) HRH4HTR1AHTR1DHTR1BMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130053372-A1 5-HT RECEPTOR MODULATORS CAMBRIDGE ENTERPRISE LIMITED 2013-02-28 US claimed
US-20130053372-A1 5-HT RECEPTOR MODULATORS CAMBRIDGE ENTERPRISE LIMITED 2013-02-28 US disclosed
US-20130053372-A1 5-HT RECEPTOR MODULATORS CAMBRIDGE ENTERPRISE LIMITED 2013-02-28 US disclosed
EP-2536711-A1 5-HT RECEPTOR MODULATORS Cambridge Enterprise Limited (GB) 2012-12-26 EP disclosed
WO-2011098776-A1 5-HT RECEPTOR MODULATORS CAMBRIDGE ENTERPRISE LIMITED (GB) 2011-08-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130053372-A1 5-HT RECEPTOR MODULATORS HTR1B, HTR5A, HTR1A HRH4 350/4885HTR6 6/4885HTR1A 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.